Biopolymer-based microparticles for encapsulation of all-trans-retinoic acid

被引:0
|
作者
Silva, Leticia A. [1 ]
Dambros, Roberta [1 ]
Leonardi, Gislaine R. [2 ]
Perrechil, Fabiana [1 ]
机构
[1] Univ Fed Sao Paulo UNIFESP, Dept Engn Quim, Diadema, SP, Brazil
[2] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
biopolymers and renewable polymers; drug delivery systems; microscopy; polysaccharides; proteins; SOLID LIPID NANOPARTICLES; COMPLEX COACERVATION; PROTEIN ISOLATE; IN-VIVO; GELATIN; FABRICATION; DELIVERY; CHITOSAN; GUM; MICROENCAPSULATION;
D O I
10.1002/app.51335
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
This work aims to investigate the potential of complex coacervation technique to encapsulate and protect all-trans retinoic acid (RA). Gelatin and kappa-carrageenan were used as wall material and pequi oil was employed as a hydrophobic phase. Three formulations with different protein: polysaccharide ratio and pH were defined to produce the microparticles based on the zeta potential and turbidity analysis: (F1) ratio 3:1 and pH 3.5, (F2) ratio 8:1 and pH 3.5, and (F3) ratio 8:1 and pH 5.0. Microparticles were evaluated regarding their morphology, yield, encapsulation efficiency (EE), and stability. The properties of microparticles were mainly affected by the protein: polysaccharide ratio and the turbidity of the mixtures, which is directly related to the protein-polysaccharide interaction. Formulation 1 showed the optimal values of yield (75.6%), EE (100.2%), and stability (85% of the encapsulated RA remained in the particle). The results demonstrated the high potential of this innovative technique to encapsulate RA for a future application in topical formulations.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] BILIARY METABOLITES OF ALL-TRANS-RETINOIC ACID IN THE RAT
    SKARE, KL
    DELUCA, HF
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 224 (01) : 13 - 18
  • [22] ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
    VISANI, G
    TOSI, P
    MANFROI, S
    OTTAVIANI, E
    FINELLI, C
    CENACCHI, A
    BENDANDI, M
    TURA, S
    LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) : 277 - 280
  • [23] TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH ALL-TRANS-RETINOIC ACID
    OHNO, R
    NAOE, T
    HIRANO, M
    KOBAYASHI, M
    HIRAI, H
    TUBAKI, K
    OH, H
    BLOOD, 1993, 81 (05) : 1152 - 1154
  • [24] ALL-TRANS-RETINOIC ACID TREATMENT AND SWEET SYNDROME
    TOMAS, JF
    ESCUDERO, A
    FERNANDEZRANADA, JM
    LEUKEMIA, 1994, 8 (09) : 1596 - 1596
  • [25] Radiologic features of all-trans-retinoic acid syndrome
    Jung, JI
    Choi, JE
    Hahn, ST
    Min, CK
    Kim, CC
    Park, SH
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 178 (02) : 475 - 480
  • [26] Physiological insights into all-trans-retinoic acid biosynthesis
    Napoli, Joseph L.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (01): : 152 - 167
  • [27] VARIABILITY IN THE ORAL BIOAVAILABILITY OF ALL-TRANS-RETINOIC ACID
    ADAMSON, PC
    PITOT, HC
    BALIS, FM
    RUBIN, J
    MURPHY, RF
    POPLACK, DG
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12) : 993 - 996
  • [28] CLINICAL-PHARMACOLOGY OF ALL-TRANS-RETINOIC ACID
    MUINDI, JRF
    YOUNG, CW
    WARRELL, RP
    LEUKEMIA, 1994, 8 (11) : 1807 - 1812
  • [29] METABOLISM OF ALL-TRANS-RETINOIC ACID IN RAT TESTIS
    CHAUDHARY, LR
    NELSON, EC
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 1985, 55 (01) : 17 - 23
  • [30] All-Trans-Retinoic Acid (ATRA) Induced Myositis
    Manglani, M. V.
    Balamurugan, P.
    INDIAN PEDIATRICS, 2009, 46 (10) : 912 - 913